#77 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
In this article, it is discussed that cannabinoids, found in cannabis, can accumulate in body fat and persistently stimulate the endocannabinoid system, which regulates nausea and vomiting. This prolonged activation may lead to a syndrome characterized by persistent nausea, vomiting, and weight loss, referred to as Cannabinoid Hyperemesis Syndrome (CHS). Clinicians should be aware of this potential complication in chronic cannabis users, especially those with recurrent abdominal pain.
💊️ In light of the article “Your questions about this horrible cannabis syndrome, answered”, it’s crucial for healthcare providers to be aware of the potential long-term effects of cannabis use, particularly in relation to a condition known as Cannabinoid Hyperemesis Syndrome (CHS). This syndrome, characterized by severe vomiting and nausea, can occur due to prolonged, frequent cannabis use. While the exact mechanism is not fully understood, it’s believed that cannabinoids can accumulate in body fat and continue stimulating the endocannabinoid system, which regulates nausea and vomiting. It’s important to note that confounders such as other underlying medical conditions or medication use may contribute to CHS. In clinical practice, healthcare providers should consider CHS as a possible diagnosis in patients presenting with recurrent vomiting, especially those with a history of heavy cannabis use. Early recognition
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
